{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:51:12Z","timestamp":1777009872018,"version":"3.51.4"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Biomarkers are considered to be helpful in diagnosing, monitoring, predicting treatment response, and prognosis in clinical practice and as outcomes in clinical trials. In this article, we review the recent literature on new biomarkers and the expanding use of older ones in vasculitic conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In antineutrophil cytoplasmic antibody-associated vasculitis patients antineutrophil cytoplasmic antibody type may be useful as a predictor of relapse and response to rituximab. Moreover, serial measurements of proteinase-3 titer may help to predict relapse. Urinary soluble CD163 levels are promising for identifying active renal vasculitis. Imaging modalities such as positron emission tomography, computerized angiography tomography, and temporal artery ultrasound maintain their role in diagnosis and disease assessment in large vessel vasculitis. Fecal calprotectin is a useful marker of active gastrointestinal involvement in Beh\u00e7et's syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The publications reviewed here potentially may help to move the field of biomarkers in vasculitis management. However, more work toward understanding the underlying pathophysiology and effects of an intervention on the disease process are needed before true biomarkers can be realized. Further studies with appropriate control groups, using good definitions for disease states such as activity and remission are needed to guide our use of these markers correctly in the management of our patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000447","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:09:43Z","timestamp":1506038983000},"page":"30-35","source":"Crossref","is-referenced-by-count":19,"title":["Biomarkers in vasculitis"],"prefix":"10.1097","volume":"30","author":[{"given":"Gulen","family":"Hatemi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem N.","family":"Esatoglu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Yazici","sequence":"additional","affiliation":[{"name":"NYU Hospital for Joint Diseases, New York University School of Medicine, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0000000000000009","article-title":"Biomarkers in vasculitis","volume":"26","author":"Monach","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14397595.2016.1192760","article-title":"Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"27","author":"Murosaki","year":"2017","journal-title":"Mod Rheumatol"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener's) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a German vasculitis referral center","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.39812","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener's): distinct patient subsets","volume":"68","author":"Miloslavsky","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/art.39814","article-title":"Association of serum calprotectin (S100A8\/A9) level with disease relapse in proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Pepper","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2015050511","article-title":"Urinary soluble CD163 in active renal vasculitis","volume":"27","author":"O\u2019Reilly","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/03009742.2015.1127410","article-title":"Serum levels of the soluble haemoglobin scavenger receptor CD163 in MPO-ANCA-associated renal vasculitis","volume":"45","author":"Nagai","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"e0158871","DOI":"10.1371\/journal.pone.0158871","article-title":"Low serum complement C3 levels at diagnosis of renal ANCA-associated vasculitis is associated with poor prognosis","volume":"11","author":"Augusto","year":"2016","journal-title":"PLoS One"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s10067-016-3384-9","article-title":"Circulating C3 levels predict renal and global outcome in patients with renal vasculitis","volume":"35","author":"Villacorta","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2016.05.015","article-title":"Glomerular C3d as a novel prognostic marker for renal vasculitis","volume":"56","author":"Villacorta","year":"2016","journal-title":"Hum Pathol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"e0165402","DOI":"10.1371\/journal.pone.0165402","article-title":"ANCA-associated glomerulonephritis: risk factors for renal relapse","volume":"11","author":"Goceroglu","year":"2016","journal-title":"PLoS One"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.humpath.2016.01.015","article-title":"The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study","volume":"52","author":"Diaz-Crespo","year":"2016","journal-title":"Hum Pathol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3899\/jrheum.160866","article-title":"Histopathological classification and renal outcome in patients with antineutrophil cytoplasmic antibodies-associated renal vasculitis: a study of 186 patients and metaanalysis","volume":"44","author":"Chen","year":"2017","journal-title":"J Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2215\/CJN.04800516","article-title":"Prognostic value of histologic classification of ANCA-associated glomerulonephritis","volume":"11","author":"Bjorneklett","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2016.11.006","article-title":"Posttranslational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory-autoimmunity connection","volume":"464","author":"Bruschi","year":"2017","journal-title":"Clin Chim Acta"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fimmu.2016.00256","article-title":"Neutrophil extracellular traps in ANCA-associated vasculitis","volume":"7","author":"Soderberg","year":"2016","journal-title":"Front Immunol"},{"key":"R23-20230829","first-page":"S98","article-title":"Neutrophil-related and serum biomarkers in granulomatosis with polyangiitis support extracellular traps mechanism of the disease","volume":"34","author":"Surmiak","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"e0148197","DOI":"10.1371\/journal.pone.0148197","article-title":"Circulating level of neutrophil extracellular traps is not a useful biomarker for assessing disease activity in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00296-017-3706-5","article-title":"Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa","volume":"37","author":"Oh","year":"2017","journal-title":"Rheumatol Int"},{"key":"R26-20230829","first-page":"1","article-title":"Association of five-factor score with the mortality in Japanese patients with polyarteritis nodosa","author":"Abe","year":"2017","journal-title":"Mod Rheumatol"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"281.e1","DOI":"10.1016\/j.jpeds.2016.07.035","article-title":"The combined usefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease","volume":"178","author":"Kawamura","year":"2016","journal-title":"J Pediatr"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1253\/circj.CJ-16-0864","article-title":"Prognostic significance of QT interval dispersion in the response to intravenous immunoglobulin therapy in Kawasaki disease","volume":"81","author":"Motoki","year":"2017","journal-title":"Circ J"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"e0161265","DOI":"10.1371\/journal.pone.0161265","article-title":"Plasma prostaglandin E2 levels correlated with the prevention of intravenous immunoglobulin resistance and coronary artery lesions formation via CD40L in Kawasaki disease","volume":"11","author":"Kuo","year":"2016","journal-title":"PLoS One"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2016.08.012","article-title":"Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease","volume":"171","author":"Ye","year":"2016","journal-title":"Clin Immunol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1253\/circj.CJ-16-0563","article-title":"Serum tenascin-C as a novel predictor for risk of coronary artery lesion and resistance to intravenous immunoglobulin in Kawasaki disease: a multicenter retrospective study","volume":"80","author":"Okuma","year":"2016","journal-title":"Circ J"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"e006703","DOI":"10.1136\/bmjopen-2014-006703","article-title":"Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis","volume":"5","author":"Lin","year":"2015","journal-title":"BMJ open"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00431-016-2798-3","article-title":"N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease","volume":"175","author":"Kwon","year":"2016","journal-title":"Eur J Pediatr"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00011-016-0942-1","article-title":"Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki disease","volume":"65","author":"Hokibara","year":"2016","journal-title":"Inflamm Res"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"e0146733","DOI":"10.1371\/journal.pone.0146733","article-title":"Urinary colorimetric sensor array and algorithm to distinguish Kawasaki disease from other febrile illnesses","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00393-015-1674-2","article-title":"Diagnostic accuracy of 18F-FDG PET or PET\/CT for large vessel vasculitis: a meta-analysis","volume":"75","author":"Lee","year":"2016","journal-title":"Z Rheumatol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"e4146","DOI":"10.1097\/MD.0000000000004146","article-title":"Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: a real-life prospective study","volume":"95","author":"Lariviere","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R39-20230829","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-017-3774-5","article-title":"Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET\/CT in detection of large-vessel involvement","author":"de Boysson","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R40-20230829","first-page":"w14397","article-title":"Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis","volume":"147","author":"Adler","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"e3851","DOI":"10.1097\/MD.0000000000003851","article-title":"18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients","volume":"95","author":"de Boysson","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/acr.22906","article-title":"Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: correlation with positron emission tomography findings","volume":"69","author":"Germano","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R43-20230829","first-page":"102","article-title":"Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study","volume":"103","author":"Pulsatelli","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1874312901711010023","article-title":"Serum cytokine profile in Asian Indian patients with Takayasu arteritis and its association with disease activity","volume":"11","author":"Goel","year":"2017","journal-title":"Open Rheumatol J"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jjcc.2016.10.016","article-title":"Profiles of serum cytokine levels in Takayasu arteritis patients: potential utility as biomarkers for monitoring disease activity","volume":"70","author":"Tamura","year":"2017","journal-title":"J Cardiol"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-155-7-201110040-00005","article-title":"Pentraxin-3 as a marker of disease activity in Takayasu arteritis","volume":"155","author":"Dagna","year":"2011","journal-title":"Ann Intern Med"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2010.10.058","article-title":"Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker","volume":"57","author":"Ishihara","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s13075-014-0479-z","article-title":"Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis","volume":"16","author":"Tombetti","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R49-20230829","first-page":"S73","article-title":"Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up","volume":"34","author":"Alibaz-Oner","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.33411","article-title":"Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia","volume":"64","author":"Baldini","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R51-20230829","article-title":"Soluble-HLA-E: a follow up biomarker in Takayasu arteritis, independent of HLA-E genotype","author":"Goel","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"e000353","DOI":"10.1136\/rmdopen-2016-000353","article-title":"Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?","volume":"3","author":"Goodfellow","year":"2017","journal-title":"RMD Open"},{"key":"R53-20230829","article-title":"Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography\/time-of-flight-mass spectrometry","author":"Ahn","year":"2017","journal-title":"Joint Bone Spine"},{"key":"R54-20230829","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6050049","article-title":"Serum profiles of cytokines in Behcet's disease","volume":"6","author":"Sadeghi","year":"2017","journal-title":"J Clin Med"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fimmu.2017.00200","article-title":"Cytokine signatures in mucocutaneous and ocular Behcet's disease","volume":"8","author":"Lopalco","year":"2017","journal-title":"Front Immunol"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2016.12.001","article-title":"An elevated pro-inflammatory cytokines profile in Behcet's disease: a multiplex analysis","volume":"186","author":"Gholijani","year":"2017","journal-title":"Immunol Lett"},{"key":"R57-20230829","first-page":"197","article-title":"Immunometabolic biomarkers of inflammation in Behcet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens","volume":"184","author":"Cantarini","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1756-185X.12832","article-title":"Serum anti-lysozyme is associated with disease activity of Behcet's disease","volume":"20","author":"Park","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s10620-017-4606-y","article-title":"Proteomic analysis of serum amyloid A as a potential marker in intestinal Behcet's disease","volume":"62","author":"Lee","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jgh.13530","article-title":"Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Behcet's disease","volume":"32","author":"Kim","year":"2017","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201801000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:01:31Z","timestamp":1693292491000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201801000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000447","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}